Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2021-09-03 Board/Management Inform…
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Board/Management Information Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces the appointment of a new Sales Director (Ivo Simundic) for a specific region (DACH). This type of announcement, detailing changes in senior management or board composition, directly aligns with the definition of Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Since it is a specific announcement about management structure, MANG is the most appropriate classification over the general Regulatory Filings (RNS). The document length (7811 chars) is substantial enough to be the primary document, not just a brief announcement of a report (RPA).
2021-09-03 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational event: a new commercial implantation of the Aeson® artificial heart at a German medical center. It includes quotes from management and medical staff, details about the procedure, and standard company boilerplate information. This format is characteristic of an announcement intended for immediate public dissemination regarding a business or operational milestone, rather than a comprehensive periodic financial report (like 10-K or IR) or a formal regulatory filing like a proxy statement or earnings release. Since it is a press release announcing a specific event (a successful commercial use/milestone), it fits best under the general category of a Regulatory Filing (RNS) if a more specific category like 'Earnings Release' (ER) or 'Capital Update' (CAP) does not apply. Given the options, 'RNS' (Regulatory Filings / General regulatory announcements) serves as the appropriate fallback for a press release detailing operational progress that isn't explicitly an earnings report or a formal statutory filing like a 10-K.
2021-08-27 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific corporate event: a new commercial implant of the Aeson® artificial heart. It includes a date (August 27, 2021), quotes from management and medical personnel, and contact information for press and investor relations. This format is characteristic of an immediate, high-level announcement of a significant operational milestone, rather than a comprehensive periodic financial report (like 10-K or IR) or a formal regulatory filing. Since it is an announcement of a business development/operational update, it fits best under the general category for significant, non-financial-specific announcements, which aligns most closely with Regulatory Filings (RNS) as a broad category for press releases, or potentially a specific operational update if one existed. Given the options, and since it is not a financial report, earnings release, or management change, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for a press release detailing operational progress.
2021-08-27 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational event: the implantation of the Aeson® artificial heart in a second US center as part of a feasibility study. It includes key details, quotes from management and the principal investigator, and standard boilerplate information about the company and forward-looking statements. This format is characteristic of an immediate corporate announcement regarding business progress, rather than a comprehensive periodic report (like 10-K or IR) or a formal regulatory filing like a DEF 14A or DVA. Since it is a press release announcing operational progress and clinical trial updates, it fits best under the general category for corporate announcements that aren't specifically earnings, management changes, or financing, making 'Regulatory Filings' (RNS) the most appropriate fallback, although 'Report Publication Announcement' (RPA) is sometimes used for announcements, this is an operational update announcement, not an announcement *of* a report release. Given the options, RNS serves as the best general regulatory/corporate announcement category when a more specific one (like ER or MANG) doesn't apply.
2021-08-25 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific corporate event: the second center implanting CARMAT's total artificial heart in the United States under an Early Feasibility Study (EFS). It includes key dates (August 25, 2021), quotes from management and investigators, and standard boilerplate information about the company and disclaimers. This format is characteristic of an initial announcement of operational or clinical progress, rather than a comprehensive periodic report (like 10-K or IR) or a formal regulatory filing for shareholder votes (like DEF 14A). Since it is an announcement of key operational news, it fits best under the general category for regulatory/corporate announcements that aren't covered by more specific codes. While it is not a formal Earnings Release (ER), it is a significant corporate update. Given the options, it is a general corporate announcement. If a more specific code existed for 'Clinical/Operational Update,' that would be ideal. Lacking that, 'RNS' (Regulatory Filings - general/miscellaneous) is the most appropriate fallback for a press release detailing clinical progress that isn't a financial report or management change.
2021-08-25 English
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces a specific corporate event: 'CARMAT announces the first human implant of its Aeson® artificial heart in Germany'. It contains quotes from the CEO and medical personnel, details about the procedure, and standard boilerplate information about the company, including contact details for Press Relations and Investor Relations. This format is characteristic of an immediate, high-level announcement of a significant event, rather than a comprehensive periodic financial report (like 10-K or IR) or a transcript of a call (CT). Since it is a press release announcing a major operational milestone (a medical implant), it does not fit neatly into the specific financial filing categories (like ER, DIV, CAP). Therefore, the most appropriate classification is the general regulatory announcement/press release category, which is RNS (Regulatory Filings), as it serves as a broad communication to the market that doesn't match the other specific definitions.
2021-07-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.